Finance

Lists
1530:HKG
3SBio Inc
HK$16.12
-4.95%
(-0.84) 1D
Aug 31, 4:08:46 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1530...
Open
HK$16.84
High
HK$16.84
Low
HK$15.94
Mkt. cap
40.78B
Avg. vol.
0.00
Volume
34.87M
Dividend
1.55%
Quarterly dividend
HK$0.06
Ex-dividend date
Jul 22, 2024
P/E ratio
4.18
52-wk high
HK$36.80
52-wk low
HK$14.81
EPS
HK$3.86
Shares outstanding
2.54B
No. of employees
6K
Open
HK$16.84
High
HK$16.84
Low
HK$15.94
Mkt. cap
40.78B
Avg. vol.
0.00
Volume
34.87M
Dividend
1.55%
Quarterly dividend
HK$0.06
Ex-dividend date
Jul 22, 2024
P/E ratio
4.18
52-wk high
HK$36.80
52-wk low
HK$14.81
EPS
HK$3.86
Shares outstanding
2.54B
No. of employees
6K
About 3SBio Inc
CEO-
Employees6.07K
Founded1993
HeadquartersShenyang, Liaoning, China
SectorBiotechnology
Website3sbio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
6.67B
6.67B
2.26B
2.26B
Cost of goods sold
354.38M
354.38M
365.70M
365.70M
Cost of revenue
354.38M
354.38M
365.70M
365.70M
Research and development expenses
486.42M
486.42M
341.92M
341.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.19B
1.19B
737.27M
737.27M
Operating expense
1.70B
1.70B
1.13B
1.13B
Total operating expenses
2.05B
2.05B
1.49B
1.49B
Operating income
4.62B
4.62B
771.21M
771.21M
Other non operating income
34.14M
34.14M
46.09M
46.09M
EBT including unusual items
4.56B
4.56B
716.94M
716.94M
EBT excluding unusual items
4.58B
4.58B
660.20M
660.20M
Income tax expense
709.43M
709.43M
111.90M
111.90M
Effective tax rate
15.55%
15.55%
15.61%
15.61%
Other operating expenses
20.37M
20.37M
46.89M
46.89M
Net income
3.56B
3.56B
573.30M
573.30M
Net profit margin
53.40%
53.40%
25.33%
25.33%
Earnings per share
-
-
-
-
Interest and investment income
109.92M
109.92M
111.68M
111.68M
Interest expense
-11.69M
-11.69M
-15.45M
-15.45M
Net interest expenses
98.23M
98.23M
96.23M
96.23M
Depreciation and amortization charges
-
-
-
-
EBITDA
4.76B
4.76B
898.20M
898.20M
Gain or loss from assets sale
3.07M
3.07M
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps